Analysis of expression and prognosis of KLK7 in ovarian cancer

Chen Erhua; Zhu Huifang; Yang Yue; Wang Ling; Zhang Jianhua; Han Yonghong; Liu Xiang

doi:10.1515/med-2020-0139

Open Medicine (Sep 2020)

Analysis of expression and prognosis of KLK7 in ovarian cancer

Chen Erhua,
Zhu Huifang,
Yang Yue,
Wang Ling,
Zhang Jianhua,
Han Yonghong,
Liu Xiang

Affiliations

Chen Erhua: Department of Pharmacy and Medicine Pharmacy, Jiang Su College of nursing, Huaian, 223005, China
Zhu Huifang: Department of Pharmacy and Medicine Pharmacy, Jiang Su College of nursing, Huaian, 223005, China
Yang Yue: Department of Pharmacy and Medicine Pharmacy, Jiang Su College of nursing, Huaian, 223005, China
Wang Ling: Department of Pharmacy and Medicine Pharmacy, Jiang Su College of nursing, Huaian, 223005, China
Zhang Jianhua: Department of Pharmacy and Medicine Pharmacy, Jiang Su College of nursing, Huaian, 223005, China
Han Yonghong: Department of Pharmacy and Medicine Pharmacy, Jiang Su College of nursing, Huaian, 223005, China
Liu Xiang: Department of Pharmacy and Medicine Pharmacy, Jiang Su College of nursing, Huaian, 223005, China

DOI: https://doi.org/10.1515/med-2020-0139
Journal volume & issue: Vol. 15, no. 1
pp. 932 – 939

Abstract

Read online

Ovarian cancer is one of the common malignant tumors in female reproductive organs. Kallikrein-related peptidase (KLK) 7 is a secreted serine peptidase that is related to different cancer. To investigate the expression and significance of KLK7 in ovarian cancer.

Published in Open Medicine

ISSN: 2391-5463 (Online)
Publisher: De Gruyter
Country of publisher: Poland
LCC subjects: Medicine
Website: https://www.degruyter.com/journal/key/med/html

About the journal

Abstract

Keywords